
HIV Treatment Bulletin - Vol. 7, No. 6, June 2006
Simon Collins, HIV i-Base
Marta Boffito and colleagues from the Chelsea and Westminster Hospital, compared absorption of saquinavir 500mg (dosed at 1000mg SQV with 100mg RTV, twice daily) when taken with a high calorie fat-containing meal (~1070kcal; 46-66g of fat), to when taken under fasted conditions. [1] An interim analysis of 10/22 patients who completed this cross-over study, where three consecutive doses were taken in either fed/fasted or fasted/fed state, separated by one week.
Administration of SQV/r under fasted conditions resulted in an approximate 70% decrease in SQV
PK parameters, and are detailed in Table 1. There was no significant change in ritonavir PK. The researchers concluded that saquinavir/r should be taken with food in order to ensure maximum therapeutic exposure.
| Table 1: Saquinavir levels (fed and fasted) | ||
| Fed | Fasted | |
| AUC ng·h/ml | 38,927 | 11,476 |
| Cmax ng/ml | 6,399 | 1,587 |
| Ctrough ng/ml | 1,294 | 373 |
Ref: Boffito M et al. Effect of a fat-containing meal on the pharmacokinetic (PK) profile of saquinavir 500mg tablet/ritonavir (SQV/r) 1000/100 mg BID in HIV-infected individuals. 7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon. Abstract 66.
2006-06-10
IB060706-18
©2006. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.